1-3 of 3
Robert F. Graziano, PhD.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lirilumab Enhances Anti-Tumor Efficacy of Elotuzumab

Caroline Sola, PhD, Mathieu Blery, PhD, Cécile Bonnafous, PhD, Elodie Bonnet, Nicolas Fuseri, Robert F Graziano, PhD, Yannis Morel, PhD, Pascale André, PhD
Journal: Blood
Blood (2014) 124 (21): 4711.
https://doi.org/10.1182/blood.V124.21.4711.4711
Published: 2014
Journal Articles

Effects of IL-21, KIR Blockade, and CD137 Agonism on the Non-Clinical Activity of Elotuzumab

Michael Robbins, BS, Maria Jure-Kunkel, DVM, PhD, Gennaro Dito, BS, Pascale Andre, PhD, Hui-fen Zhang, PhD, Natalie Bezman, PhD, Robert F Graziano, PhD
Journal: Blood
Blood (2014) 124 (21): 4717.
https://doi.org/10.1182/blood.V124.21.4717.4717
Published: 2014
Journal Articles

Characterization of MDX-1401, a Human Anti-CD30 Antibody with Enhanced Effector Function, for Therapy of Malignant Lymphoma.

Pina M. Cardarelli, PhD., Cristina Loomis, PhD., Ben Preston, Amelia Black, PhD., David Passmore, PhD., Tseng-Hui Chen, PhD., Sharline Chen, Jie Liu, PhD., Michelle R Kuhne, PhD, Mohan Srinivasan, PhD., Albert Assad, MD, Alison Witte, Marco Coccia, PhD, Robert F. Graziano, PhD., David J. King, PhD.
Journal: Blood
Blood (2008) 112 (11): 1580.
https://doi.org/10.1182/blood.V112.11.1580.1580
Published: 2008